Georgia lawyers Mike McGlamry and Kirk Pope this week represented nearly 250 of the 3,000 people who settled claims over problems with hip replacements for an expected $1 billion-plus.
According to a release from the firm, the agreement was reached after four months of negotiations between New Jersey-based Stryker, which manufacturered the modular Rejuvenate or AQBG II implants, and recipients of the devices who’ve experienced metal poisoning and other adverse events.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
